Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2b

Clinical trial NCT06967987 · WITHDRAWN

Trial details

NCT number: NCT06967987
Sponsor: Institut Cancerologie de l'Ouest
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric and Gastro-oesophageal Junction (GEJ) Adenocarcinomas Overexpression FGFR2b

Start date: 2026-01-01
Primary completion: 2026-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.